Physiologic versus diabetogenic effects of interleukin-1: a question of weight
- PMID: 24588826
- DOI: 10.2174/1381612820666140130204401
Physiologic versus diabetogenic effects of interleukin-1: a question of weight
Abstract
Pleiotropic effects, great potency, and the capacity to induce its own production are distinguishing characteristics of IL-1. Among the multiple physiological effects of this cytokine, we emphasize here its role in supporting immune processes by stimulating most immune cells, and in re-setting glucose homeostasis. These aspects are complementary because stimulatory actions of IL-1 may be due to its capacity to increase glucose uptake by immune cells in the periphery and to affect the control of glucose homeostasis at brain levels, so as to deviate this main fuel to immune cells during inflammatory and infectious diseases. Thus, IL-1 can contribute to maintain a lean phenotype, inhibit food intake, and exert hypoglycemic effects. However, these effects of IL-1 can be overridden particularly when it is overproduced ectopically in other tissues, as it occurs during the autoimmune process that destroys the pancreas and causes type 1 diabetes, or when obesity triggers its production in adipose tissue and influences the development of type 2 diabetes. During obesity, products of enlarged adipocytes, e.g. fatty acids, are sensed as danger signals by infiltrating immune cells and, together with hypoxia, results in an ectopic overproduction of IL-1 that is largely mediated by activation of the NLRP3-caspase-1 inflammasome. Insulin and leptin resistance develops by mutual IL-1β-TNFα induction, and hyperglycemia causes ectopic production of IL-1 in the pancreas, which deregulates insulin production and favors the development of type 2 diabetes. In conclusion, whether IL-1 exerts physiologic or pathologic effects depends on its amount and on the spatial and temporal pattern of its production.
Similar articles
-
IL-1 resets glucose homeostasis at central levels.Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):16039-44. doi: 10.1073/pnas.0607076103. Epub 2006 Oct 11. Proc Natl Acad Sci U S A. 2006. PMID: 17035503 Free PMC article.
-
Recent advances in the relationship between obesity, inflammation, and insulin resistance.Eur Cytokine Netw. 2006 Mar;17(1):4-12. Eur Cytokine Netw. 2006. PMID: 16613757 Review.
-
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients.Clin Exp Immunol. 2015 Oct;182(1):35-44. doi: 10.1111/cei.12667. Epub 2015 Jul 19. Clin Exp Immunol. 2015. PMID: 26095630 Free PMC article.
-
A casein hydrolysate protects mice against high fat diet induced hyperglycemia by attenuating NLRP3 inflammasome-mediated inflammation and improving insulin signaling.Mol Nutr Food Res. 2016 Nov;60(11):2421-2432. doi: 10.1002/mnfr.201501054. Epub 2016 Sep 8. Mol Nutr Food Res. 2016. PMID: 27390025
-
Hypothalamic Insulin Resistance in Obesity: Effects on Glucose Homeostasis.Neuroendocrinology. 2017;104(4):364-381. doi: 10.1159/000455865. Epub 2017 Jan 26. Neuroendocrinology. 2017. PMID: 28122381 Review.
Cited by
-
Effects of Dietary Intervention on Inflammatory Markers in Metabolic Syndrome: A Systematic Review and Meta-Analysis.Front Nutr. 2022 Mar 31;9:846591. doi: 10.3389/fnut.2022.846591. eCollection 2022. Front Nutr. 2022. PMID: 35433780 Free PMC article.
-
Brain-borne IL-1 adjusts glucoregulation and provides fuel support to astrocytes and neurons in an autocrine/paracrine manner.Mol Psychiatry. 2016 Sep;21(9):1309-20. doi: 10.1038/mp.2015.174. Epub 2015 Dec 8. Mol Psychiatry. 2016. PMID: 26643538
-
Anti- and non-tumor necrosis factor-α-targeted therapies effects on insulin resistance in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.World J Diabetes. 2021 Mar 15;12(3):238-260. doi: 10.4239/wjd.v12.i3.238. World J Diabetes. 2021. PMID: 33758645 Free PMC article. Review.
-
Macrophages in obesity are characterised by increased IL-1β response to calcium-sensing receptor signals.Int J Obes (Lond). 2022 Oct;46(10):1883-1891. doi: 10.1038/s41366-022-01135-x. Epub 2022 Aug 5. Int J Obes (Lond). 2022. PMID: 35931812 Free PMC article.
-
Salsalate: a pleotropic anti-inflammatory drug in the treatment of diabetes, obesity, and metabolic diseases.Inflammopharmacology. 2023 Dec;31(6):2781-2797. doi: 10.1007/s10787-023-01242-9. Epub 2023 Sep 27. Inflammopharmacology. 2023. PMID: 37758933 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical